<http://schema.org/description>
"Vivus's better-than-expected Phase III data with obesity drug Qnexa started the goldmine versus graveyard debate once again. In one corner: the folks who think obesity is the last frontier. In the other corner: the folks like BNET's own Jim Edwards, who argues that obesity drugs are doomed to failure."^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.cbsnews.com/news/why-vivuss-qnexa-might-avoid-the-obesity-drug-graveyard/>